0000000000109718

AUTHOR

John P. A. Ioannidis

showing 15 related works from this author

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants

2012

Abstract: Background Two recent studies identified a mutation (p.Asp620Asn) in the vacuolar protein sorting 35 gene as a cause for an autosomal dominant form of Parkinson disease. Although additional missense variants were described, their pathogenic role yet remains inconclusive. Methods and results We performed the largest multi-center study to ascertain the frequency and pathogenicity of the reported vacuolar protein sorting 35 gene variants in more than 15,000 individuals worldwide. p.Asp620Asn was detected in 5 familial and 2 sporadic PD cases and not in healthy controls, p.Leu774Met in 6 cases and 1 control, p.Gly51Ser in 3 cases and 2 controls. Overall analyses did not reveal any sig…

MaleParkinson's diseasePopulationVesicular Transport ProteinsLocus (genetics)DiseaseBiologyVPS35 protein humanBioinformaticsgenetics [Vesicular Transport Proteins]genetics [Parkinson Disease]Risk Factorsmedicinemetabolism [Vesicular Transport Proteins]GeneticsMissense mutationVPS35 GeneHumansGenetic epidemiologyGenetic Predisposition to Diseaseddc:6101506Genome-wideeducationGenetics (clinical)Genetic Association StudiesGeneticsVacuolar protein sortingeducation.field_of_studyGenotype-Phenotype CorrelationsParkinson DiseaseComplex traitsmedicine.diseasePenetranceddc:MutationFemaleHuman medicineParkinson-s diseaseJournal of Medical Genetics
researchProduct

Effect of low-dose aspirin on health outcomes: An umbrella review of systematic reviews and meta-analyses.

2020

Aims:\ud \ud This study aimed to use an umbrella review methodology to capture the range of outcomes that were associated with low‐dose aspirin and to systematically assess the credibility of this evidence.\ud \ud Methods:\ud \ud Aspirin is associated with several health outcomes, but the overall benefit/risk balance related to aspirin use is unclear. We searched three major databases up to 15 August 2019 for meta‐analyses of observational studies and randomized controlled trials (RCTs) including low‐dose aspirin compared to placebo or other treatments. Based on random‐effects summary effect sizes, 95% prediction intervals, heterogeneity, small‐study effects and excess significance, signifi…

medicine.medical_specialtyPopulationLower riskPlacebo030226 pharmacology & pharmacySystematic Reviews and Meta‐analysisRisk Assessmentlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineHumansPharmacology (medical)aspirin cancer cardiovascular disease meta-analysis umbrella review030212 general & internal medicineeducationPharmacologyAspirineducation.field_of_studyAspirinbusiness.industrytechnology industry and agriculturemedicine.diseaseMeta-analysisObservational studylipids (amino acids peptides and proteins)Upper gastrointestinal bleedingbusinessGastrointestinal Hemorrhagemedicine.drug
researchProduct

A common biological basis of obesity and nicotine addiction

2013

Contains fulltext : 128630.pdf (Publisher’s version ) (Open Access) Smoking influences body weight such that smokers weigh less than non-smokers and smoking cessation often leads to weight increase. The relationship between body weight and smoking is partly explained by the effect of nicotine on appetite and metabolism. However, the brain reward system is involved in the control of the intake of both food and tobacco. We evaluated the effect of single-nucleotide polymorphisms (SNPs) affecting body mass index (BMI) on smoking behavior, and tested the 32 SNPs identified in a meta-analysis for association with two smoking phenotypes, smoking initiation (SI) and the number of cigarettes smoked …

obesityFOOD-INTAKETAG Consortiummedicine.medical_treatmentOxford-GSK ConsortiumLOCIIcelandAetiology screening and detection [ONCOL 5]VARIANTS3124 Neurology and psychiatryNicotine0302 clinical medicineDEPENDENCE030212 general & internal medicineAge of OnsetENGAGE consortiumPOPULATIONAddiction; Body Mass Index; Nicotine dependence; Smokingmedia_commonPsychiatry2. Zero hunger0303 health scienceseducation.field_of_studyASSOCIATIONTobacco Use DisorderDSM-VCANCER3142 Public health care science environmental and occupational health3. Good healthPsychiatry and Mental healthMeta-analysis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingOriginal ArticleaddictionLife Sciences & Biomedicinemedicine.drugmedicine.medical_specialtymedia_common.quotation_subjectPopulationbody mass indexPolymorphism Single Nucleotidesmoking03 medical and health sciencesCellular and Molecular NeuroscienceSDG 3 - Good Health and Well-beingInternal medicinemedicineHumansSMOKING-BEHAVIORnicotine dependencePsychiatryeducationBiological PsychiatryMolecular epidemiology Aetiology screening and detection [NCEBP 1]030304 developmental biologyScience & Technologybusiness.industryAddictionAppetitemedicine.diseaseObesityBODY-MASS INDEXBehavior AddictiveEndocrinologySmoking cessationbusinessBody mass indexTranslational Psychiatry
researchProduct

Updated Field Synopsis and Systematic Meta-Analyses of Genetic Association Studies in Cutaneous Melanoma: The MelGene Database

2015

We updated a field synopsis of genetic associations of cutaneous melanoma (CM) by systematically retrieving and combining data from all studies in the field published as of August 31, 2013. Data were available from 197 studies, which included 83,343 CM cases and 187,809 controls and reported on 1,126 polymorphisms in 289 different genes. Random-effects meta-analyses of 81 eligible polymorphisms evaluated in4 data sets confirmed 20 single-nucleotide polymorphisms across 10 loci (TYR, AFG3L1P, CDK10, MYH7B, SLC45A2, MTAP, ATM, CLPTM1L, FTO, and CASP8) that have previously been published with genome-wide significant evidence for association (P5 × 10(-8)) with CM risk, with certain variants pos…

SLC45A2Skin NeoplasmsLocus (genetics)DermatologyPolymorphism Single NucleotideBiochemistryLinkage DisequilibriumGermlineStatistical significanceDatabases GeneticOdds RatioHumansGenetic Predisposition to DiseaseMelanomaGeneMolecular BiologyGerm-Line MutationGenetic associationGeneticsbiologyChromosome MappingGenetic VariationCell BiologyGene Expression Regulation NeoplasticCutaneous melanomabiology.proteinGenome-Wide Association StudyJournal of Investigative Dermatology
researchProduct

Efficacy and acceptability of pharmacological and non-pharmacological interventions for non-specific chronic low back pain: a protocol for a systemat…

2020

Abstract Background Despite the enormous financial and humanistic burden of chronic low back pain (CLBP), there is little consensus on what constitutes the best treatment options from a multitude of competing interventions. The objective of this network meta-analysis (NMA) is to determine the relative efficacy and acceptability of primary care treatments for non-specific CLBP, with the overarching aim of providing a comprehensive evidence base for informing treatment decisions. Methods We will perform a systematic search to identify randomised controlled trials of interventions endorsed in primary care guidelines for the treatment of non-specific CLBP in adults. Information sources searched…

Adultmedicine.medical_specialtyPsychological interventionMEDLINEMedicine (miscellaneous)lcsh:Medicinenot knownlaw.inventionRS03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Randomized controlled trialMeta-Analysis as TopiclawmedicineProtocolHumansLow back pain030212 general & internal medicineFunctional abilityNetwork meta-analysisExercisebusiness.industrylcsh:RBayes TheoremLow back painClinical trialRandomized controlled trialMeta-analysisPhysical therapySystematic reviewQuality of Lifemedicine.symptombusiness030217 neurology & neurosurgerySystematic Reviews as TopicSystematic Reviews
researchProduct

Metformin and health outcomes:An umbrella review of systematic reviews with meta-analyses

2021

Background:\ud \ud The objective was to capture the breadth of outcomes that have been associated with metformin use and to systematically assess the quality, strength and credibility of these associations using the umbrella review methodology.\ud \ud Methods:\ud \ud Four major databases were searched until 31 May 2020. Meta‐analyses of observational studies and meta‐analyses of randomized controlled trials (RCTs) (including active and placebo control arms) were included.\ud \ud Results:\ud \ud From 175 eligible publications, we identified 427 different meta‐analyses, including 167 meta‐analyses of observational studies, 147 meta‐analyses of RCTs for metformin vs placebo/no treatment and 11…

MaleGRADE meta-analysis metformin umbrellamedicine.medical_specialtyPregnancy Rateendocrine system diseasesClinical Biochemistry030204 cardiovascular system & hematologyOverweightBiochemistryBody Mass Indexlaw.invention03 medical and health sciences0302 clinical medicineMeta-Analysis as TopicRandomized controlled trialPregnancylawNeoplasmsInternal medicinemedicineHumansHypoglycemic AgentsObesity030212 general & internal medicinePrediabetesbusiness.industryGeneral MedicineOverweightProtective Factorsmedicine.diseaseMetforminMetforminDiabetes Mellitus Type 1Systematic reviewDiabetes Mellitus Type 2Cardiovascular DiseasesMeta-analysisFemaleObservational studymedicine.symptombusinessInfertility FemaleBody mass indexPolycystic Ovary SyndromeSystematic Reviews as Topicmedicine.drug
researchProduct

The association of depression and all-cause and cause-specific mortality: An umbrella review of systematic reviews and meta-analyses

2018

Background Depression is a prevalent and disabling mental disorder that frequently co-occurs with a wide range of chronic conditions. Evidence has suggested that depression could be associated with excess all-cause mortality across different settings and populations, although the causality of these associations remains unclear. Methods We conducted an umbrella review of systematic reviews and meta-analyses of observational studies. PubMed, PsycINFO, and Embase electronic databases were searched through January 20, 2018. Systematic reviews and meta-analyses that investigated associations of depression and all-cause and cause-specific mortality were selected for the review. The evidence was g…

EXCESS MORTALITYmental disorderSurvivalENVIRONMENTAL RISK-FACTORS*Meta-analysesPsychological interventionlcsh:MedicineCREDIBILITY CEILINGSPsycINFOUNIPOLAR DEPRESSIONACUTE CORONARY SYNDROME0302 clinical medicineMedicine*Cause-specific030212 general & internal medicineDepression (differential diagnoses)METABOLIC SYNDROMEPsychiatryDepressionConfoundingSEVERE MENTAL-ILLNESSBIPOLAR DISORDERGeneral Medicine11 Medical And Health SciencesCausalityCause-specificSystematic reviewHEART-FAILURE*Mortality*Umbrella reviewLife Sciences & Biomedicine*SurvivalResearch ArticleBF*All-cause03 medical and health sciencesUmbrella reviewMedicine General & InternalGeneral & Internal MedicineHumansMortalityCARDIOVASCULAR EVENTSDepressive DisorderScience & Technologybusiness.industrylcsh:RAll-causeSystematic reviews*Depression030227 psychiatryPROGNOSTIC ASSOCIATIONMYOCARDIAL-INFARCTIONMeta-analysesStructured interview*PsychiatryObservational study*Systematic reviewsbusinessDemography
researchProduct

Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and…

2020

Objective Two previous individual participant data meta-analyses (IPDMAs) found that different diagnostic interviews classify different proportions of people as having major depression overall or by symptom levels. We compared the odds of major depression classification across diagnostic interviews among studies that administered the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). Methods Data accrued for an IPDMA on HADS-D diagnostic accuracy were analysed. We fit binomial generalized linear mixed models to compare odds of major depression classification for the Structured Clinical Interview for DSM (SCID), Composite International Diagnostic Interview (CIDI), and…

MaleDepressive disordersSCHEDULESACCURACYSocio-culturaleHospital Anxiety and Depression ScaleOdds03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingIndividual participant data meta-analysisMedicineHumansMajor depression030212 general & internal medicineVALIDITYDepression (differential diagnoses)Mini-international neuropsychiatric interviewProbabilityPsychiatric Status Rating ScalesDepressive Disorder MajorDepressive disorders Diagnostic interviews Hospital Anxiety and Depression Scale Individual participant data meta-analysis Major depressionbusiness.industryIndividual participant dataOdds ratioCIDIAn individual participant data meta-analysis of 73 primary studies.- Journal of psychosomatic research cilt.129 ss.109892 2020 [Wu Y. Levis B. Sun Y. Krishnan A. He C. Riehm K. Rice D. Azar M. Yan X. Neupane D. et al. -Probability of major depression diagnostic classification based on the SCID CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale - Depression subscale scores]3. Good healthPsychiatry and Mental healthClinical PsychologyHospital Anxiety and Depression ScaleMeta-analysisDiagnostic interviews/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalebusiness030217 neurology & neurosurgeryClinical psychology
researchProduct

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

2012

Bone mineral density (BMD) is the most widely used predictor of fracture risk. We performed the largest meta-analysis to date on lumbar spine and femoral neck BMD, including 17 genome-wide association studies and 32,961 individuals of European and east Asian ancestry. We tested the top BMD-associated markers for replication in 50,933 independent subjects and for association with risk of low-trauma fracture in 31,016 individuals with a history of fracture (cases) and 102,444 controls. We identified 56 loci (32 new) associated with BMD at genome-wide significance (P < 5 × 10 -8). Several of these factors cluster within the RANK-RANKL-OPG, mesenchymal stem cell differentiation, endochondral…

MaleBone densityOsteoporosisGenome-wide association studyMitochondrial Membrane Transport ProteinsBone densitometryFractures Bone0302 clinical medicineBone DensityRisk FactorsFemurGeneticsBone mineral0303 health scienceseducation.field_of_studyExtracellular Matrix ProteinsLumbar VertebraeFemur Neckta3141medicine.anatomical_structureLow Density Lipoprotein Receptor-Related Protein-5/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingIntercellular Signaling Peptides and ProteinsFemaleGensmusculoskeletal diseases/dk/atira/pure/subjectarea/asjc/1300/1311GenotypePopulationEuropean Continental Ancestry GroupQuantitative Trait Loci030209 endocrinology & metabolismVèrtebres lumbarsBiologyFèmurPolymorphism Single NucleotideArticleWhite People03 medical and health sciencesSDG 3 - Good Health and Well-beingDensitometria òssiaGeneticsmedicineHumansGenetic Predisposition to Diseaseeducation030304 developmental biologyFemoral neckGenetic associationGlycoproteinsGene Expression ProfilingComputational BiologySpectrinta3121medicine.diseasePhosphoproteinsGenesOsteoporosisMesenchymal stem cell differentiationHuman medicineFracturesGenome-Wide Association Study
researchProduct

Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysis.

2020

Objectives Validated diagnostic interviews are required to classify depression status and estimate prevalence of disorder, but screening tools are often used instead. We used individual participant data meta-analysis to compare prevalence based on standard Hospital Anxiety and Depression Scale – depression subscale (HADS-D) cutoffs of ≥8 and ≥11 versus Structured Clinical Interview for DSM (SCID) major depression and determined if an alternative HADS-D cutoff could more accurately estimate prevalence. Methods We searched Medline, Medline In-Process & Other Non-Indexed Citations via Ovid, PsycINFO, and Web of Science (inception-July 11, 2016) for studies comparing HADS-D scores to SCID major…

AdultMalemedicine.medical_specialtyMEDLINEDiagnostic interviewScale Individual participant dataHospital Anxiety and Depression Scale03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingHospital Anxiety and DepressionInternal medicinePrevalenceMedicineHumansScreening tool030212 general & internal medicineDepression (differential diagnoses)Screening toolsAgedDepressive Disorder Majorbusiness.industryDepressionIndividual participant dataIndividual participant dataMiddle AgedConfidence interval3. Good healthPsychiatry and Mental healthClinical PsychologyHospital Anxiety and Depression ScaleMeta-analysisMeta-analysis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalebusiness030217 neurology & neurosurgeryJournal of psychosomatic research
researchProduct

Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies

2018

The development of depression may involve a complex interplay of environmental and genetic risk factors. PubMed and PsycInfo databases were searched from inception through August 3, 2017, to identify meta-analyses and Mendelian randomization (MR) studies of environmental risk factors associated with depression. For each eligible meta-analysis, we estimated the summary effect size and its 95% confidence interval (CI) by random-effects modeling, the 95% prediction interval, heterogeneity with I 2 , and evidence of small-study effects and excess significance bias. Seventy meta-analytic reviews met the eligibility criteria and provided 134 meta-analyses for associations from 1283 primary studie…

MOOD DISORDERSPUBLISHED LITERATURELongevityPsycINFORisk Assessment17 Psychology And Cognitive Sciences03 medical and health sciencesUmbrella review0302 clinical medicineMendelian randomizationIMPAIRED GLUCOSE-METABOLISMmedicineHumansOLDER-ADULTSBiological PsychiatryDepression (differential diagnoses)PsychiatryScience & Technologybusiness.industryDepressionPreventiongenetic risk factorPrediction intervalMAJOR DEPRESSION11 Medical And Health SciencesMendelian Randomization Analysismedicine.diseaseADEQUATE PARENTAL CAREMental healthConfidence intervalADULT DEPRESSION030227 psychiatryDepression; Meta-analyses; Prevention; Psychiatry; Risk factors; Umbrella reviewSYSTEMATIC REVIEWSPsychiatry and Mental healthSystematic reviewMood disordersRisk factorsMeta-analysesINDIVIDUAL PARTICIPANT DATAbusinessLife Sciences & BiomedicineMENTAL-HEALTH030217 neurology & neurosurgeryDemography
researchProduct

Correspondence to Sand et al. “Critical Reappraisal of a Catechol-O-Methyltransferase Transversion Variant in Schizophrenia”

2010

GeneticsCatechol-O-methyl transferaseSchizophrenia (object-oriented programming)GenotypeBiologyTransversionBiological PsychiatryBiological Psychiatry
researchProduct

Additional file 3 of Efficacy and acceptability of pharmacological and non-pharmacological interventions for non-specific chronic low back pain: a pr…

2020

Additional file 3. Researcher allegiance.

researchProduct

Additional file 2 of Efficacy and acceptability of pharmacological and non-pharmacological interventions for non-specific chronic low back pain: a pr…

2020

Additional file 2. MEDLINE search string.

TheoryofComputation_MISCELLANEOUSComputingMethodologies_PATTERNRECOGNITIONInformationSystems_INFORMATIONSTORAGEANDRETRIEVALData_FILES
researchProduct

Additional file 1 of Efficacy and acceptability of pharmacological and non-pharmacological interventions for non-specific chronic low back pain: a pr…

2020

Additional file 1. PRISMA-P checklist.

researchProduct